Home › Acute Myeloid Leukemia › New York › Queens
Acute Myeloid Leukemia clinical trials in Queens, NY
21 studies for Acute Myeloid Leukemia are looking for participants at sites in and around Queens (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Queens Hospital Center, Jamaica · 2 mi away
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
RecruitingPhase 1
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi away
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi away
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecruitingPhase 2
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi away
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi away
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi away
A Study of CRD3874-SI in People With Leukemia
RecruitingPhase 1
- Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre · 10 mi away
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi away
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi away
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi away
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RecruitingPhase 3
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park · 9 mi away
- NYU Langone Hospital - Long Island, Mineola · 11 mi away
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
RecruitingPhase 2
- Clinical Research Allicance, Westbury · 14 mi away
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park · 9 mi away
- NYU Langone Hospital - Long Island, Mineola · 11 mi away
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
RecruitingPhase 3
- Cohen Children's Medical Center, Queens
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- Northwell Health, LLC PRIME, Lake Success · 9 mi away
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
RecruitingPhase 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · 10 mi away
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
RecruitingPhase 1
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi away
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
RecruitingPhase 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · 10 mi away
A Study of Revumenib and Mezigdomide in People With Leukemia
RecruitingPhase 1/2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre · 10 mi away
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
RecruitingPhase 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · 10 mi away
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
RecruitingPhase 2/3
- New York University Langone Hospital - Long Island, Mineola · 11 mi away
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
RecruitingPhase 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi away
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
RecruitingPhase 2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre · 10 mi away
About Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) is a cancer of the white blood cells. AML usually gets worse quickly if it is not treated. Read more.
More about Acute Myeloid Leukemia on MedlinePlus
Acute Myeloid Leukemia trials in other cities
- Houston, TX85 studies
- New York City, NY51 studies
- Boston, MA44 studies
- Baldwin Park, CA40 studies
- Seattle, WA40 studies
- Columbus, OH35 studies
- Philadelphia, PA34 studies
- Durham, NC33 studies
- Atlanta, GA30 studies
- Tampa, FL29 studies
- Chicago, IL26 studies
- Portland, OR25 studies
Other studies in Queens
- Breast Cancer63 studies
- Non-Small Cell Lung Cancer49 studies
- Colorectal Cancer31 studies
- Metastatic Cancer28 studies
- Ovarian Cancer28 studies
- Prostate Cancer27 studies
- Cancer (all types)26 studies
- Endometrial Cancer25 studies
- Lung Cancer22 studies
- Head and Neck Squamous Cell Carcinoma20 studies
- Multiple Myeloma20 studies
- Pancreatic Cancer20 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.